A novel delivery modality named "FLASH" radiotherapy (FLASH-RT) has emerged recently. 1 Although radiotherapy facilities are currently set to deliver dose rates around 0.05-0.40 Gy/s (CONV) in 2 Gy daily fractions accumulated to reach the tolerance limit of normal tissues undergoing irradiation, FLASH-RT relies on ultrahigh dose rate facilities and consists of delivering a large dose in a single microsecond pulse, or in a few pulses given over a very short time. FLASH-RT was established using 4-6 MeV electrons with intra-pulse dose rates in the range 10 6 -10 7 Gy/s 1 and was found to spare the lung of C57BL/6J mice exposed to 15 Gy by bilateral thorax irradiation from radiation-induced fibrosis while preserving the antitumor efficacy in xenografted as well as orthotopic, syngeneic models. 1 These features have been confirmed by other teams in adult and juvenile mouse brain, mouse tail, mouse and pig skin, cat muzzle, zebrafish, and mouse intestine (for a review, see the article "Radiobiology of the FLASH effect" in the same issue of the journal). Research groups investigating the feasibility of FLASH-RT with proton beams 2 have found promising results, with gut sparing from necrosis after 18 Gy 230 MeV protons FLASH-RT delivered at 78 Gy/s 3 and reduced lung fibrosis and skin dermatitis after proton FLASH exposures at 40 Gy/s. 4 Corroborating observations made 39 years ago with mouse tail necrosis as an endpoint, 5 Montay-Gruel et al. recently demonstrated that sparing the adult and juvenile mouse brain from radiation-induced gliosis, loss of neural stem cells, and impaired memory by ultrahigh dose rate irradiation is, at least in part, an oxygen-dependent process. 6,7 In support of this idea, carbogen breathing was found to reverse the neuroprotective effect of FLASH-RT. 6 In addition,